Cargando…

Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression

An adequate blood supply is essential for cancer cells to survive and grow; thus, the concept of inhibiting tumor angiogenesis has been applied to cancer therapy, and several drugs are already in clinical use. It has been shown that treatment with those anti-angiogenic drugs improved the response ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Hisatsugu, Nishioka, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796048/ https://www.ncbi.nlm.nih.gov/pubmed/29286323 http://dx.doi.org/10.3390/ijms19010098

Ejemplares similares

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
por: Mitsuhashi, Atsushi, et al.
Publicado: (2015)

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017)

Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer
por: Tobiume, Makoto, et al.
Publicado: (2022)

Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain
por: Kawano, Hiroshi, et al.
Publicado: (2020)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Fibrocytes in health and disease
por: Blakaj, Adriana, et al.
Publicado: (2012)

Fibrocytes in primary myelofibrosis
por: Shimoda, Kazuya, et al.
Publicado: (2021)

Targeting fibrocytes in autoimmunity
por: Bucala, Richard J.
Publicado: (2022)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Circulating fibrocyte mobilization in negative pressure wound therapy
por: Chen, Dezhi, et al.
Publicado: (2017)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
por: Xu, Donghan, et al.
Publicado: (2023)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Fibrocytes and the tissue niche in lung repair
por: Andersson-Sjöland, Annika, et al.
Publicado: (2011)

Trypsin Potentiates Human Fibrocyte Differentiation
por: White, Michael J. V., et al.
Publicado: (2013)

Role of Circulating Fibrocytes in Cardiac Fibrosis
por: Lin, Rong-Jie, et al.
Publicado: (2016)

The emerging role of fibrocytes in ocular disorders
por: Zhang, Feng, et al.
Publicado: (2018)

Fibrocytes, Wound Healing, and Corneal Fibrosis
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2020)

Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
por: Vasudev, Naveen S., et al.
Publicado: (2014)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020)

Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target
por: Huang, Jun, et al.
Publicado: (2013)

Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
por: Cao, Mengyuan, et al.
Publicado: (2022)

IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators
por: Tezuka, Toshifumi, et al.
Publicado: (2015)

Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis
por: Ashley, Shanna L., et al.
Publicado: (2016)

Characterization of Circulating Fibrocytes in People Living with HIV on Stable Antiretroviral Therapy
por: Dean, Logan S., et al.
Publicado: (2022)

Immunohistochemical analysis of stromal fibrocytes and myofibroblasts to envision the invasion and lymph node metastasis in oral squamous cell carcinoma
por: Rao, Sowmya J, et al.
Publicado: (2017)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Future options of anti-angiogenic cancer therapy
por: Cao, Yihai
Publicado: (2016)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Erratum to: Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
por: Vasudev, Naveen S., et al.
Publicado: (2014)

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
por: Pisarsky, Laura, et al.
Publicado: (2016)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
por: Schiffmann, Lars M., et al.
Publicado: (2022)

Extracellular vesicles in tumor angiogenesis and resistance to anti‐angiogenic therapy
por: Ye, Zi‐Wu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7lra3arn78gf02hv338bs2e219